Rivaroxaban, Aspirin, or Both to Prevent Early Coronary Bypass Graft Occlusion: The COMPASS-CABG Study

Andre Lamy1, John Eikelboom2, Tej Sheth2

  • 1Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada; CADENCE Research Group, Hamilton Health Sciences, Hamilton, Ontario, Canada; Department of Surgery, McMaster University, Hamilton, Ontario, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.

Insights

Rivaroxaban plus aspirin did not prevent graft failure after coronary artery bypass graft surgery. However, the combination therapy showed a similar reduction in major adverse cardiovascular events as seen in the COMPASS trial.

Area of Science:

  • Cardiovascular Surgery
  • Pharmacology
  • Clinical Trials

Background:

  • Patients undergoing coronary artery bypass graft (CABG) surgery face risks of early graft failure, myocardial infarction, and death.
  • The COMPASS trial demonstrated rivaroxaban plus aspirin reduced major adverse cardiovascular events (MACE) compared to aspirin alone.
  • Rivaroxaban 5 mg twice daily monotherapy did not significantly reduce MACE in the COMPASS trial.

Purpose of the Study:

  • To evaluate the efficacy of COMPASS trial treatments in preventing graft failure and MACE post-CABG.
  • To compare rivaroxaban plus aspirin, rivaroxaban alone, and aspirin alone in a CABG patient substudy.

Main Methods:

  • A substudy of 1,448 COMPASS trial patients randomized 4-14 days post-CABG.
  • Treatment groups included rivaroxaban plus aspirin, rivaroxaban alone, or aspirin alone.
  • Primary outcome was graft failure assessed by CT angiogram at 1 year; MACE was a secondary outcome.

Main Results:

  • Neither rivaroxaban plus aspirin nor rivaroxaban alone reduced graft failure rates compared to aspirin alone.
  • The combination of rivaroxaban and aspirin showed a trend towards fewer MACE compared to aspirin alone (HR: 0.69; p=0.34).
  • Rivaroxaban alone did not significantly alter MACE rates compared to aspirin alone; no fatal bleeding or tamponade occurred within 30 days.

Conclusions:

  • Rivaroxaban 2.5 mg twice daily plus aspirin or rivaroxaban 5 mg twice daily alone did not reduce graft failure post-CABG.
  • The combination of rivaroxaban and aspirin demonstrated similar MACE reductions as observed in the broader COMPASS trial.
  • These findings suggest a potential role for combination therapy in managing cardiovascular risk after CABG, warranting further investigation.
Abstract

Related Concept Videos

Compass01:23

Compass

The compass is a fundamental instrument that operates by aligning its magnetic needle with Earth's magnetic field. This alignment facilitates navigation and orientation, offering a means to determine direction relative to magnetic north. However, the magnetic needle points to magnetic north, which differs slightly from true geographic north due to magnetic declination, which is the angular deviation between these two points. Declination varies based on geographic location and shifts over time...
6.8K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
686
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
268
Design Example: Marking Boundaries of a Site Using a Compass01:12

Design Example: Marking Boundaries of a Site Using a Compass

Marking site boundaries using a compass is a precise surveying technique that ensures the accuracy of boundary delineation. The process begins by using provided site details, including the bearings and lengths of each boundary line. The initial step involves calculating latitudes and departures for all sides of the site. This computation verifies that the traverse is free of errors, ensuring a closed and accurate boundary.The process starts at a known point, such as Point A, which is often...
291
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
330
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.1K